Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of ExpertsAvagimyan A.,
Fogacci F.,
Pogosova N.,
Kakrurskiy L.,
Kogan E.,
Urazova O.,
Kobalava Z.,
Mikhaleva L.,
Vandysheva R.,
Zarina G.,
Trofimenko A.,
Navasardyan G.,
Mkrtchyan L.,
Galli M.,
Jndoyan Z.,
Aznauryan A.,
Saahakyan K.,
Agati L.,
Shafie D.,
Cicero A.,
Di Salvo G.,
Sarrafzadegan N. pathways responsible for the
diabetic cardiomyopathy development. This review aims to appraise and discuss
Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activationQian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. of
diabetic cardiomyopathy (DCM). This study aims to explore the non-inflammatory mechanisms mediated by MD2
Modern notions of health of newborns from mothers with gestational diabetes mellitusThe aimed of the study was to research of health of newborns from mothers with gestational
diabetes Curcumin analogue C66 attenuates obesity-induced myocardial injury by inhibiting JNK-mediated inflammationYe, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. Obesity has been recognized as a major risk factor for the development of chronic
cardiomyopathy The problem of classification of cardiomyopathiesThe problem of classification of
cardiomyopathies